Bacteria in cancer initiation, promotion and progression
G El Tekle, WS Garrett - Nature Reviews Cancer, 2023 - nature.com
Cancer cells originate from a series of acquired genetic mutations that can drive their
uncontrolled cell proliferation and immune evasion. Environmental factors, including the …
uncontrolled cell proliferation and immune evasion. Environmental factors, including the …
Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications
E Tshibangu-Kabamba, Y Yamaoka - Nature Reviews Gastroenterology …, 2021 - nature.com
Helicobacter pylori is a major human pathogen for which increasing antibiotic resistance
constitutes a serious threat to human health. Molecular mechanisms underlying this …
constitutes a serious threat to human health. Molecular mechanisms underlying this …
[PDF][PDF] 第五次全国幽门螺杆菌感染处理共识报告
刘文忠, 谢勇, 陆红, 成虹, 曾志荣, 周丽雅, 陈烨… - 中华消化杂志, 2017 - file.medtrib.cn
由中华医学会消化病学分会幽门螺杆菌(Hp) 和消化性溃疡学组主办的“幽门螺杆菌感染处理
maastricht 5 共识研讨会暨第五次全国幽门螺杆菌感染处理共识会” 于2016 年12 月15~ 16 …
maastricht 5 共识研讨会暨第五次全国幽门螺杆菌感染处理共识会” 于2016 年12 月15~ 16 …
AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review
The purpose of this CPU Expert Review is to provide clinicians with guidance on the
management of Helicobacter pylori after an initial attempt at eradication therapy fails …
management of Helicobacter pylori after an initial attempt at eradication therapy fails …
Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions
A Savoldi, E Carrara, DY Graham, M Conti… - Gastroenterology, 2018 - Elsevier
Background & Aims In 2017, the World Health Organization (WHO) designated
clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and …
clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and …
Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges
Helicobacter pylori (H. pylori) infection, which affects approximately half of the world's
population, remains a serious public health problem. As H. pylori infection leads to a number …
population, remains a serious public health problem. As H. pylori infection leads to a number …
ACG clinical guideline: treatment of Helicobacter pylori infection
Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …
Peptic ulcer disease
The rapidly declining prevalence of Helicobacter pylori infection and widespread use of
potent anti-secretory drugs means peptic ulcer disease has become substantially less …
potent anti-secretory drugs means peptic ulcer disease has become substantially less …
Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin
Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …
disorders. These drugs are well tolerated in the short term, but long-term treatment was …
Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options
Peptic ulcer is a chronic disease affecting up to 10% of the world's population. The formation
of peptic ulcers depends on the presence of gastric juice pH and the decrease in mucosal …
of peptic ulcers depends on the presence of gastric juice pH and the decrease in mucosal …